Tytuł pozycji:
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif® in healthy Chinese subjects
-
Tytuł:
-
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif in healthy Chinese subjects
-
Autorzy:
-
Liu, Guangwen
Xue, Jinling
Wang, Yanli
Liu, Zhengzhi
Li, Xue
Qu, Dongmei
Su, Zhengjie
Xu, Kaibo
Qu, Xinyao
Qu, Zhaojuan
Sun, Linlin
Cao, Mingming
Wang, Ying
Chen, Xuesong
Yu, Jing
Liu, Lang
Deng, Qiaohuan
Zhao, Yicheng
Zhang, LixiuAff5, IDs00432022041481_cor19
Yang, HaimiaoAff1, IDs00432022041481_cor20
-
Źródło:
-
Journal of Cancer Research and Clinical Oncology. 149(6):2585-2593
-